Bicycle Therapeutics (BCYC)
(Delayed Data from NSDQ)
$22.66 USD
+0.45 (2.03%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $22.60 -0.06 (-0.26%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -1.10 |
EPS Last Quarter | -0.62 |
Last EPS Surprise | 50.79% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.44 |
Next Year | -5.01 |
EPS (TTM) | -4.45 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.61M | 7.45M | 41.93M | 35.57M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 12.30M | 12.30M | 56.50M | 55.00M |
Low Estimate | 5.00M | 5.00M | 35.00M | 20.00M |
Year ago Sales | 11.40M | 5.35M | 26.98M | 41.93M |
Year over Year Growth Est. | -33.25% | 39.21% | 55.43% | -15.18% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.10 | -1.20 | -4.44 | -5.01 |
# of Estimates | 7 | 6 | 8 | 7 |
Most Recent Consensus | -1.08 | -1.21 | -4.75 | -4.89 |
High Estimate | -0.90 | -0.95 | -3.49 | -4.08 |
Low Estimate | -1.35 | -1.46 | -5.32 | -5.83 |
Year ago EPS | -1.41 | -1.26 | -5.08 | -4.44 |
Year over Year Growth Est. | 21.99% | 4.76% | 12.60% | -12.85% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.10 | -1.20 | -4.44 | -5.01 |
7 Days Ago | -1.10 | -1.20 | -4.44 | -5.01 |
30 Days Ago | -1.10 | -1.20 | -4.44 | -5.01 |
60 Days Ago | -1.10 | -1.20 | -4.44 | -5.01 |
90 Days Ago | -1.28 | -1.33 | -5.20 | -5.82 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.10 | -1.20 | -4.44 | -5.01 |
Zacks Consensus Estimate | -1.10 | -1.20 | -4.44 | -5.01 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.62 | -1.16 | -1.26 | -1.41 | NA |
Estimate | -1.26 | -1.23 | -1.06 | -1.10 | NA |
Difference | 0.64 | 0.07 | -0.20 | -0.31 | 0.05 |
Surprise | 50.79% | 5.69% | -18.87% | -28.18% | 2.36% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more